Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Alfresa Holdings rises for third day on plan to acquire medical device maker Nagashima Medical Instruments
Alfresa Holdings Corporation <2784> gained for a third consecutive session. After the market close on May 27, the company announced it will acquire all shares of Tokyo-based Nagashima Medical Instruments, a medical device manufacturer specializing in otolaryngology and head and neck surgery, buoying investor sentiment.
Through the acquisition, ALFRESA expects to strengthen the group's manufacturing and development capabilities in the medical device sector, expand its proprietary product lineup, and boost sales opportunities through collaboration with its pharmaceutical wholesaling business. Financial terms were not disclosed, and the company stated that the impact on its earnings for the fiscal year ending March 2027 will be minimal.
Source: MINKABU PRESS
*Translated by generative AI. Click here for the original article.
Related Articles
Bushiroad shares mixed after raising net profit forecast on New Japan Pro-Wrestling stake sale
South Korean KOSPI opens at 8,165.73 on the 28th, down 62.97 points
Singapore Nikkei 225 futures open at 65,035 yen on the 28th, down 20 yen
U.S. stocks overview on the 27th: Dow Jones up 182 points, reaching record highs with Nasdaq
U.S. forex market summary: dollar rises to 159.50 yen level amid Middle East uncertainty
Oncolys BioPharma surges on European patent intention notice for endoscopic administration of OBP-301
Tokyo stocks seen firm on May 28 as falling crude oil prices provide support
AI revolution and dangerous scent of polarized market ahead
Oricon, Postponed Dividend for This Fiscal Year
ITO EN, Ordinary Profit Forecast for Last Fiscal Year Revised Upward to an Unexpected 1% Increase